Weight-Loss Drugs Under Scrutiny: Are GLP-1 Treatments Safe For Wider Use?
Are popular GLP-1 weight-loss drugs safe? India steps up checks as demand rises and cheaper generics prepare to enter the market.
Indian Pharma Firms Introduce Generic Semaglutide Injections For Diabetes & Obesity Treatment
Indian drugmakers launch affordable semaglutide injections after patent expiry, expanding access for diabetes and obesity patients across the country.
WHO Warns: Obesity Crisis Needs More Than Medicines
WHO says GLP-1 drugs help treat obesity, but cannot solve the global crisis without lifestyle changes, early intervention, and equitable access.
Indian Pharma Market Up 7.9% In July; Cardiac & Diabetes Lead
The Indian pharmaceutical market (IPM) expanded by 7.9% in July 2025, according to a recent Pharmarack report.
